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Abstract 
The mechanisms of immune privilege in human nucleus pulposus (NP) remain unclear. Accumu-
lating evidence indicates that Fas ligand (FasL) might play an important role in the immune privilege 
of the disc. We aimed for addressing the role of FasL expression in human intervertebral disc 
degeneration (IDD) and immune privilege in terms of the interaction between NP cells and im-
munocytes via the FasL-Fas machinery. We collected NP specimens from 20 patients with IDD as 
degenerative group and 8 normal cadaveric donors as control. FasL expression was detected by 
qRT-PCR, western blotting and flow cytometry (FCM). We also collected macrophages and CD8+ 
T cells from the peripheral blood of patients with IDD for co-cultures with NP cells. And mac-
rophages and CD8+ T cells were harvested for apoptosis analysis by FCM after 2 days of 
co-cultures. We found that FasL expression in mRNA, protein and cellular resolutions demon-
strated a significant decrease in degenerative group compared with normal control (p<0.05). FCM 
analysis found that human NP cells with increased FasL expression resulted in significantly in-
creased apoptosis ratio of macrophages and CD8+ T cells. Our study demonstrated that FasL 
expression tends to decrease in degenerated discs and FasL plays an important role in human disc 
immune privilege, which might provide a novel target for the treatment strategies for IDD. 
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Introduction 
Intervertebral disc degeneration (IDD) is a major 
cause of many spinal disorders [1, 2]. Over the past 
decade, the underlying mechanisms of IDD have been 
well documented in terms of biomechanics [3], cell 
apoptosis [4, 5], deregulated genes and microRNAs 
(miRNAs) [6, 7]. Moreover, studies with human disc 
cells, especially focusing on nucleus pulposus (NP) 
cells, are seldom found in the literature. Despite in-
tensive basic and clinical pieces of studies aiming for 
addressing the issues, the physiopathological mecha-
nisms of IDD remain yet speculative with particular 
reference to the maintenance of immune privilege. 
The immune privilege of tissues is ascribed not only 








expression of Fas ligand (FasL).  
As the largest avascular organ in the human 
body, the intervertebral disc is isolated from the host 
immune system [8]. Many pieces of evidence indicate 
the immune privilege of the disc, the chief of which is 
NP [9-11]. As an important death receptor of immune 
privilege, FasL is expressed on activated T cells, NK 
cells, and in immune privileged sites [12], i.e., eyes, 
ovary, placenta[13-15], transplantation organs [16-20]. 
Various levels of the expression of FasL have been 
noted in both degenerative and non-degenerative NP 
[21-23]. It has been consequently hypothesized that 
the Fas-FasL death complex may play a role upon 
maintaining the immune privilege of the disc.  
Cross-linking of FasL with Fas leads to apoptosis 
via a complex signaling pathway [24]. In immune 
privileged sites, activated cytotoxic T lymphocytes 
(CTLs) and macrophages can recognize target cells 
and subsequently become activated. The FasL in these 
cells binds to Fas on the surface of the target cells and 
induces apoptosis. Alternatively, when the target cells 
express FasL, CTLs or macrophages might die of 
apoptosis via the same pathway. This mechanism 
protects the disc from auto-immune attack [13].  
The FasL expression of the disc samples from 
patients with IDD and cadavers was seldom reported 
due to the paucity of human samples. It has been 
noted that FasL exists in human intervertebral disc 
cells, especially in NP cells [22, 25]. Furthermore, we 
found that deregulated miR-155 promotes 
Fas-mediated apoptosis in human intervertebral disc 
degeneration by targeting FADD and CASP3. How-
ever, the FasL derivation remains largely unknown. 
Nevertheless, the difference of FasL expression be-
tween degenerative and normal NP tissues is still un-
clear. Accordingly, the purpose of this study was to 
address the role of FasL expression in human inter-
vertebral disc degeneration (IDD) and immune privi-
lege in terms of the interaction between NP cells and 
immunocytes via the FasL-Fas machinery. 
Materials and Methods 
Sample collection 
The NP samples and peripheral blood mononu-
clear cells (PBMCs) collection for experimental appli-
cation was approved by our institutional Ethics Re-
view Board of Xijing hospital (No. 20090611-3, No. 
20111103-7). Moreover, we obtained written informed 
consents from each patient. For cadaveric donors, we 
obtained the same style of written informed consents 
from their relatives. Human NP specimens were col-
lected from patients with IDD undergoing discectomy 
as degenerative NP samples [n=20; average age 
43.4±5.4 (range 35-52)] and normal cadaveric donors 
as control [n=8; average age 41.8±3.6 (range 37-47)] 
(Table 1). The cadavers and patients included in con-
trol and experimental groups are matched for age, 
with no smoking, diabetes, hypertension and radicu-
lar symptoms, etc. All the the patients with disc de-
generation were strictly selected by MRI and in-
traoperative findings to exclude NP samples that had 
herniated outside the annulus. The degeneration de-
gree was graded by magnetic resonance imaging 
(MRI) according to the Pfirrmann’s grading system 
[26]. As for the cadavers, MRI data in records were 
collected. All the samples were dissected carefully 
under magnification and subsequently managed un-
der various schemes according to the corresponding 
procedures. 
 
Table 1. Demographic data of cadaveric donors and pa-
tients. 
NO. Age Gender Level Degree* 
Normal control  
1 44 M L4/5 I 
2 38 M L4/5 I 
3 37 F L4/5 I 
4 45 M L4/5 I 
5 47 M L4/5 I 
6 39 F L4/5 I 
7 45 M L4/5 I 
8 39 M L4/5 I 
IDD Group 
9 47 F L4/5 IV 
10 52 M L4/5 IV 
11 43 F L4/5 V 
12 36 F L4/5 IV 
13 42 M L4/5 V 
14 50 F L5/S1 IV 
15 45 F L5/S1 IV 
16 41 M L4/5 IV 
17 38 M L4/5 IV 
18 35 F L5/S1 V 
19 39 M L4/5 IV 
20 42 F L5/S1 IV 
21 52 M L4/5 IV 
22 42 M L4/5 IV 
23 46 M L4/5 IV 
24 38 F L4/5 IV 
25 49 F L4/5 IV 
26 36 M L5/S1 IV 
27 43 F L4/5 IV 
28 51 M L4/5 IV 
* Pfirrmann’s grading system. 
 




NP cell cultures 
Human NP cells were isolated from interverte-
bral disc tissues during surgical procedures for pa-
tients and dissection for cadaveric donors. After 
carefully washed, annulus fibrosus and cartilaginous 
endplate were removed under the microscope. The 
remain tissues were then minced and digested for 40 
min at 37°C in PBS with 0.25% pronase (Gibco-BRL, 
Carlsbad, CA, USA). Then solution was removed, 
remaining tissue washed, and digested for 4 h in PBS 
with 0.025% collagenase type II (Invitrogen). The di-
gest was then washed three times and filtered through 
a 45-µm pore-size nylon mesh. Cells were plated and 
expanded for 3 weeks in DMEM/F12-based culture 
medium, containing 15% fetal bovine serum (FBS; 
Gibco-BRL) and 1% penicillin/streptomycin (Invi-
trogen) in a 5% CO2 incubator. The culture medium 
was changed every three days. NP cells of Passage 1 
or 2 were used for our experiments. 
Western blotting analysis 
To determine the FasL expression level of NP 
cells in IDD patients and cadaveric donors, the cul-
tured NP cells were trypsinized. Prepare total cell 
lysates by solubilizing cells in 2X SDS sample buffer. 
Following electrophoresized in 10% gel, proteins were 
transfered to PVDF membrane. The membranes were 
incubated for 1 h at room temperature with rabbit 
polyclonal antibody specific to FasL (Santa Cruz Bio-
technology, CA, USA), and mouse monoclonal anti-
body specific to β-actin (Sigma, Saint Louis, USA) as 
control. Antibody labeling was identified using IRDye 
800 anti-rabbit or anti-mouse IgG antibody 
(LI-COR Biosciences, Nebraska, USA). Expression 
levels were analyzed by LI-COR Odyssey Imaging 
System. 
RNA isolation and qRT-PCR 
NP cells from cadavers and patients with IDD 
were harvested, and total RNA was isolated using the 
Trizol reagent (Invitrogen, Carlsbad, CA, USA) ac-
cording to the manufacturer’s instructions.  
Reverse transcription to cDNA was performed 
using a High-Capacity cDNA Archive Kit (ABI, Foster 
City, CA, USA). Predesigned primers for human FasL 
and human GAPDH as control were purchased from 
Sangon (Sangon, Shanghai, China). RNA concentra-
tions were measured using a NanoDrop instrument ( 
NanoDrop, Wilmington, DE, USA). The levels of FasL 
mRNA were normalized to GAPDH mRNA controls. 
All RT reactions, including GAPDH controls, were 
run in triplicate in a GeneAmp PCR 9700 Thermocy-
cler (ABI). The relative amounts of FasL mRNA were 
calculated using the comparative Ct (2−ΔΔCt) method. 
The primers used in the study included: FasL for-
ward: 5’- TTGCCTTGGTAGGATTGG-3’, reverse: 
5’-ATGGACCTTGAGTTGGACTT-3’;  GAPDH for-
ward: 5’-GCACCGTCAAGGCTGAGAAC-3’, reverse: 
5’- TGGTGAAGACGCCAGTGGA-3’). 
PBMCs collection 
PBMCs were isolated from whole blood by Fi-
coll-Hypaque density gradient centrifugation as re-
ported previously. Briefly, the peripheral blood was 
obtained in heparinized vacutainer collection tubes 
from IDD patients and diluted 1:3 in RPMI-1640 
(Gibco, Grand Island, NY, USA).Then 30 mL diluted 
blood was slowly layered over 15 mL Ficoll-Paque 
(GE Healthcare, Piscataway, NJ, USA), and centri-
fuged at 800×g for 30 min at room temperature. The 
PBMCs were subsequently collected for macrophage 
separation.  
Isolation and cultures of macrophages from 
patients with IDD 
The PBMCs collected from the patients with IDD 
were washed three times with RPMI-1640, and plated 
in tissue culture dishes (BD Bioscience, San Diego, 
CA, USA) at 3×106 cells/mL in RPMI-1640 supple-
mented with 2 mM L-glutamine (Gibco), 100 U/mL 
penicillin (Gibco), 100 μg/mL streptomycin (Gibco), 
0.1 mM sodium pyruvate (Gibco), 1% non-essential 
amino acids (Gibco), 50μM 2-mercaptoethanol (Gib-
co), and 10% fetal bovine serum (Gibco). After 24 h, 
the PBMCs in tissue culture dishes were washed gen-
tly with RPMI-1640 to remove a majority of the 
non-adherent cells. The monocytes which had been 
adherent in the dishes were cultured for an additional 
five days supplemented with 18 ng/ mL GM-CSF 
(PeproTech, Rocky Hill, NJ, USA) and 20 ng/mL 
M-CSF (PeproTech). Thereafter, the cells were washed 
with RPMI-1640 to remove the non-adherent or dead 
cells. The remaining adherent cells that had been in-
duced to differentiate into macrophages were scraped 
from the plate and stained with the monoclonal anti-
body CD68-PE (eBioscience, San Diego, CA, USA) in 
FCM analysis to confirm the purity of the cells prior to 
the next steps. 
Isolation of CD8+ T cells 
CD8+ T cells were positively isolated from the 
whole blood of IDD patients using the CD8+ T-cell 
Positive Isolation Kit (Invitrogen Dynal AS, Norway) 
according to the manufacturer’s instructions. Over 
90% of the CD8+ T-cell isolation was confirmed by 
FCM analysis with monoclonal antibody CD8a-APC 
(eBioscience, San Diego, CA, USA). 




Up-regulation of FasL with lentiviral vector 
The lentiviral vector labeled with green fluores-
cent protein (GFP) encoding FasL and a scrambled 
sequence as control were purchased from Genechem. 
Human NP cells were plated at a density of 1.5×105 
cells/well in a 24-well plate in a final volume of 250 µl 
complete medium. Viral solutions at a multiplicity of 
infection (MOI) of 10 were added to NP cells. Fol-
lowing 10 h of incubation at 37°C, the cells were al-
lowed to recover over the ensuing 96h in culture me-
dium. Culture flasks were detected by fluorescent 
microscopy to verify cell transfection.  
Indirect co-cultures of NP cells and immuno-
cytes 
Transwell inserts (0.4μm pore-size) were utilized 
for non-contacting co-culture in six-well plates. The 
co-culture ratio is 50:50, consisted of NP cells with 
CD8+T cells or macrophages from the same patient. 
NP cells were plated into six-well plate (1.5×106 per 
well) with 10% DMEM/F12 culture medium men-
tioned above, macrophages or CD8+T cells (1.5×106 
per well) were plated into Transwell inserts respec-
tively with same culture medium, respectively. Eight 
groups with different combinations of cell types were 
defined in this study (Table 2). Macrophage and 
CD8+T cell were harvested after 2 days of culture for 
FCM apoptpsis analysis. 
 
Table 2 Groups for co-cultures of human NP cells and 
immunocytes 





 macrophages CD8+ T 
cells 
1 +   +  
2  +  +  
3   + +  
4    +  
5 +    + 
6  +   + 
7   +  + 
8     + 
+: Cell types in each group. 
IDD: intervertebral disc degeneration. 
NP cells: nucleus pulposus cells. 
 
Flow cytometry (FCM) analysis 
To address apoptosis in macrophages and CD8+ 
T cells after co-cultures, we performed FCM with 
Annexin V-FITC/PI (BD Biosciences, San Diego, CA, 
USA) staining upon the aforementioned treated cells, 
In brief, after washing twice with PBS, 1×106 cells 
were re-suspended in binding buffer. Annexin 
V-FITC and PI were added and then incubated at 
room temperature for 15 min. The samples were then 
analyzed by FCM. Each experiment was repeated for 
at least three times.  
Statistical analysis 
Analysis of two-group parameters was per-
formed with Student’s t-test. Comparisons of multiple 
group data were performed with ANOVA test. The 
threshold of significance was set as P-value<0.05. The 
statistical analysis was performed with the SPSS 12.0 
statistical package (SPSS, Chicago, IL, USA). 
Results 
FasL expressed in human degenerative and 
normal NP cells with different resolutions  
The levels of mRNA expression of FasL in NP 
cells of non-degenerative group were significantly 
higher than those of the degenerative group (Figure 
1A). Western blotting analysis further showed that the 
intensity of FasL in non-degenerated group was 
higher than that in the degenerated group (Figure 1B). 
Quantitative analysis revealed that the average FasL 
ratio in the degenerated group was 56%±0.09, where-
as the average FasL ratio in the non-degenerated 
group was 89%±0.12 (p<0.05). 
To compare FasL expression in degenerated and 
non-degenerated tissues, we also performed FCM 
analysis to identify the level of FasL in NP cells quan-
titatively. As shown in Figure 1C, the average ratio of 
FasL positive cells (68.8%±0.072) in non-degenerative 
NP cells is significantly higher than in degenerative 
NP cells (35.4%±0.053) (p<0.05).  
Up-regulated FasL of NP cells resulted in in-
creased immunocyte apoptosis after 
co-cultures 
The cultured NP cells from patients with IDD in 
our study were in good growing condition (Figure 
2A). Macrophages were successfully isolated and 
cultured (Figure 2B). The purity of macrophages and 
CD8+T cells was detected by FCM. The 
GFP-expressing lentiviral vector transfection at a MOI 
of 10 encoding FasL resulted in high-level GFP ex-
pression in NP cells (Figure 2C). FCM detection re-
vealed the apoptosis of immunocytes in different 
groups (Figure 3A). As for macrophages without 
co-cultures, the apoptosis rate was 4.8%±0.007. Ap-
proximately 6.5%±0.0075 macrophages were apop-
totic when cultured with IDD NP cells. It was note-
worthy that NP cells with up-regulated FasL resulted 
in about 17.5%±0.012 apoptosis rate of macrophages 




(p<0.05). In the lentiviral-control group with scram-
bled sequence, the apoptosis rate of macrophages was 
6%±0.008 (Figure 3B). Similar findings were observed 
in CD8+ T cells co-cultured with NP cells (Figure 3C). 
Discussion 
IVD degeneration is the major cause in neck or 
low back pain and disc herniation, which are the most 
common disorders leading to morbidity [27]. Apop-
tosis in IVD was initially reported by Gruber in 1998. 
And more and more evidences indicating that apop-
tosis plays an important role in human degenerative 
diseases. As one of the most important pathways of 
apoptosis, cell surface death receptor pathway is cru-
cial in IVD process. In death receptor pathway, liga-
tion of Fas ligand to the Fas receptor on the cell 
membrane leads to the recruitment and activation of 
caspase-8, which will activates downstream caspases 
and results in apoptosis [27]. This mechanism also 
works in some autoimmune diseases, helps to main-
tain the balance of self-antigen and immune system. 
We found that FasL expression in 
non-degenerated NP was significantly higher than in 
degenerated discs. So far, the study is the first in suc-
cessfully establishing an in vitro model addressing the 
interaction of human NP cells and immunocytes. By 
modulating the FasL expression in degenerative NP 
cells co-cultured with immunocytes, we found that 
the degenerative NP cells with up-regulated FasL 
resolution would induce the apoptosis of invaded 
macrophages and CD+8 T cells, which contributes 
to the immune privilege of NP. Furthermore, this 
study is the first clarifying the underlying mecha-
nisms of immune privilege of human interverte-
bral disc via FasL-Fas network. 
The immune privilege of NP is not only due 
to the simple physiological barrier, but FasL ex-
pression as molecular mechanisms. Most immune 
privileged organs express FasL [13, 28-30]. Previ-
ously studies on the expression of FasL in NP cells 
from normal intervertebral disc of mature Spra-
gue-Dawley rats and humans suggested that the 
Fas-FasL system may play a key role as the un-
derlying mechanisms for maintaining the immune 
privilege of the disc [22]. FasL expression levels 
alter in NP during intervertebral disc formation 
[31]. The apoptosis in human NP is closely linked 
with autocrine or paracrine FasL mechanisms [10, 
25]. However, most studies used NP samples from 
herniated lumbar disc, animals, and patients with 
scoliosis [23], which might not well represent the 
degeneration process in the body. 
 
 
Fig 1. FasL expression of NP cells in different levels from 
degenerative and normal NP. A. qRT-PCR analysis of FasL 
expression. B. Western blotting detection of FasL expression. C. 
Flow cytometry detection of FasL positive cells. Data are repre-
sentative of six independent experiments. Error bars represent SEM. 
*p<0.05. 
 






Fig 2. NP cells, macrophages and CD8+T cells from patients with intervertebral disc degeneration were detected. A. Cultured NP cells 
for 14 days. Scale bars = 500 µm. B. Cultured macrophages for 7 days from peripheral blood of patients with disc degeneration. Scale bars = 50 µm. C. 
Brightfield (left) and fluorescent (right) microscopy of human NP cells 96 h following transfection with lentivirus labeled with green fluorescent protein. 
Scale bars = 20 µm. 
 
 
In this study, we collected non-degenerative ca-
daveric disc specimens as normal control. Moreover, 
we performed comprehensive analysis on FasL ex-
pression by qRT-PCR, western blotting and FCM. We 
carefully removed annulus fibrosus and cartilaginous 
endplate under the microscope in aseptic conditions 
due to the high degree of sensitivity of NP tissues. 
Our results based upon the multiple lines of evidence 
indicate a significant decrease of FasL expression in 
degenerative NP compared with normal discs in hu-
mans. 
Our study clarified the mechanisms of the role of 
FasL-Fas network in human NP and shed light on the 
derivation of FasL in human disc. NP has been sug-
gested to trigger an autoimmune response if exposed 
to the immune system in animal experiments as well 
as in patients with disc herniation [27, 32-35]. Both 
FasL and Fas are expressed by human T lymphocytes 
[36] and NP cells [21, 22, 25]. FasL is one of the major 
effectors of CTLs to destroy target cells [37, 38]. As in 
most immune privileged organs, the FasL-Fas net-
work is involved in the apoptotic pathways and im-
mune privilege [12]. It is well established that eyes, as 
a typical immune privileged site, constitutively ex-
presses FasL to control the spread of inflammation by 
killing Fas positive lymphoid cells that invade the 
tissue [13]. As well, FasL plays key roles in 
CTL-mediated tissue destruction under pathological 
conditions such as graft-versus-host disease (GVHD) 
[39] and experimental autoimmune diseases [40, 41]. 
Soluble and membrane-bound FasL can activate a 
cascade of caspases that culminates in apoptosis via 
binds to cell surface Fas [42, 43]. However, the role of 
FasL-Fas network in human NP cells has not been 
clarified until now. We found that FasL expression in 
non-degenerative cadaveric NP samples is higher 
than in that in degenerative NP (grade IV and V). In 
normal NP, the expression of FasL could induce the 
apoptosis of immune cells. However, in the scenario 
of degenerated NP, FasL expression decreases, which 
was further confirmed by our preliminary study since 
we tried to down-regulate FasL expression via RNAi 
but failed. The apoptosis rate between immune cell 
group and immune cells co-cultured with NP cell 




group is not statistically different because of the low 
level expression of FasL in degenerated NP. Our 
findings indicate that the combination of FasL of 
normal NP cells to Fas positive T cell triggers the 
apoptosis of CTLs, which help keep the immune 
privileged condition of NP. Co-cultures of human NP 
cells with up-regulated FasL with auto-CD8+T cells 
and macrophages, the apoptosis ratio of immunocytes 
significantly increased. These results suggest that 
FasL plays an important role in the immune privilege 
of human NP.  
Despite our de novo in vitro model, we 
acknowledge that several shortcomings exist in our 
study. First, we didn't compare living patient degen-
erative NP cells with living patient normal NP cells 
because of clinical and ethical reasons. Secondly, we 
only up-regulated the FasL expression of NP cells by 
lentiviral vector without down-regulating the expres-
sion. This is partly due to the low expression level of 
FasL in NP tissue in our preliminary study (data not 
shown). Furthermore, we selected macrophages and 
CD8+ T lymphocytes as representatives of immuno-
cytes despite we are fully aware of the complicated 
interaction within the body, such as NK cells, CD4+ T 
lymphocytes. However, the impact of NK cells and 
CD4+ T lymphocytes in human IDD remains un-
known. Further studies are needed to address 
these issues.  
 
 
Fig 3. Flow cytometry apoptosis analysis of immuno-
cytes after co-cultures. A. Contour diagram of Annexin 
V-FITC/PI FCM of human NP cells. The graphs stand for typical 
results of cell apoptosis; values represent the means for three 
experiments. B. Comparison of apoptotic cells in various mac-
rophages groups (*p<0.05). Data are representative of three 
experiments. Error bars represent SEM. C. Comparison of 
apoptotic cells in various CD8+T cell groups (*p<0.05). Data are 
representative of three experiments. Error bars represent SEM. 
 
Conclusions 
The study is the first in successfully es-
tablishing an in vitro model addressing the 
interaction of human NP cells and immuno-
cytes. Our study clarifies the mechanisms of 
the role of FasL-Fas network in human NP and 
shed light on the derivation of FasL in human 
disc. 
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